Clear Street Markets LLC Novartis Ag Transaction History

Clear Street Markets LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$92.27 - $101.54 $4.69 Million - $5.16 Million	50,851 New	50,851 $5.13 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $418,375 - $474,403	4,522 Added 452200.0%	4,523 $455,000
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $167,742 - $194,529	-2,096 Reduced 99.95%	1 $0
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $158,428 - $194,014	2,097 New	2,097 $190,000
Q2 2022 Aug 02, 2022	SELL	$80.52 - $93.75 $80 - $93	-1 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$80.11 - $90.62 $80 - $90	1 New	1 $0
Q2 2019 Jul 16, 2019	SELL	$75.4 - $92.8 $414,700 - $510,400	-5,500 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$75.32 - $86.15 $414,259 - $473,825	5,500 New	5,500 $529,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Street Markets LLC with notifications on news.